Hormonal Treatments for Heavy Menstrual Bleeding
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Recruiting
Observational Study
Heavy Menstrual Bleeding
Bleeding Disorder
Von Willebrand Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 10 – 24
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Oregon Health and Science University · Other
Who this trial is looking for
This trial is looking for young people aged 10-24 with heavy menstrual bleeding and certain bleeding disorders. Participants will try one of two hormonal treatments for 6 months and share their experiences and health outcomes.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 10 and 24 years old.
- I have started getting my period.
- I want to try treatment with either LNG-IUD or NETA.
- I can get consent from my parent if I am under 18.
- I have heavy menstrual bleeding.
- I have been diagnosed with a bleeding disorder or have ruled one out.
You may not be able to join if
- I am pregnant.
- I want to become pregnant.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this multicenter prospective observational study and registry of U.S. adolescents and young adults with heritable bleeding disorders is to determine the bleeding outcomes, satisfaction, hemostatic parameter changes, and patient reported quality of life after 6 months of use of either of two commonly used hormonal treatments for menstrual suppression - levonorgestrel intrauterine device…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Post-menarcheal
* Ages 10-24
* Decision to initiate a trial of progestin therapy with either LNG-IUD or NETA
* Able to provide assent and written informed consent by one parent (ages \<18) or written informed consent (age 18+)
* Must meet trial criteria for heavy menstrual ble…
Contacts